Buy PSNL by Nov 30, 2026.

TLDR: PSNL looks like an opportunity with very limited downside risk (low single digit %) due to an earlier merger agreement with Tempus and yet potentially triple digit % return if the merger deal is to fall through, which looks increasingly likely after the Moderna cancer vaccine update. Guys, I think I just noticed a textbook case of reflexivity - PSNL, Personalis. This tiny and very little known company powers the engine behind the recently hyped Merck-Moderna cancer vaccine. Despite …